scholarly journals Large-Scale Beard Extraction Enhances the Cosmetic Results of Scalp Hair Restoration in Advanced Androgenetic Alopecia in East Asian Men: A Retrospective Study

2019 ◽  
Vol 10 (1) ◽  
pp. 151-161
Author(s):  
De-Cong Zhu ◽  
Ye He ◽  
Zhe-Xiang Fan ◽  
Jin Wang ◽  
Qian Qu ◽  
...  

Significance It is the only country in South-east Asia with a large-scale nuclear plant, although this was never loaded with fuel. Other countries in the region have tentative plans to develop nuclear power programmes. Impacts The current absence of nuclear power programmes will help avert the diversion of capital from renewable energy development in the region. South-east Asian countries with small, non-power reactors, built for research, will try to maintain these facilities. Across the region, the need for electricity grid investment will increase as more decentralised generation sources are deployed.


2021 ◽  
Vol 49 (6) ◽  
pp. 456-462
Author(s):  
Suat Gormel ◽  
◽  
Salim Yasar ◽  
Serkan Asil ◽  
Erhan Bozkurt ◽  
...  

2017 ◽  
Vol 30 (14) ◽  
pp. 5597-5603 ◽  
Author(s):  
Xian Chen ◽  
Zhong Zhong ◽  
Wei Lu

The NCEP–NCAR reanalysis dataset and the tropical cyclone (TC) best-track dataset from the Regional Specialized Meteorological Center (RSMC) Tokyo Typhoon Center were employed in the present study to investigate the possible linkage of the meridional displacement of the East Asian subtropical upper-level jet (EASJ) with the TC activity over the western North Pacific (WNP). Results indicate that summertime frequent TC activities would create the poleward shift of the EASJ through a stimulated Pacific–Japan (PJ) teleconnection pattern as well as the changed large-scale meridional temperature gradient. On the contrary, in the inactive TC years, the EASJ is often located more southward than normal with an enhanced intensity. Therefore, TC activities over the WNP are closely related to the location and intensity of the EASJ in summer at the interannual time scale.


2019 ◽  
Vol 57 (4) ◽  
Author(s):  
Rory M. Welsh ◽  
D. Joseph Sexton ◽  
Kaitlin Forsberg ◽  
Snigdha Vallabhaneni ◽  
Anastasia Litvintseva

ABSTRACT The emerging yeast Candida auris can be highly drug resistant, causing invasive infections, and large outbreaks. C. auris went from an unknown pathogen a decade ago to being reported in over thirty countries on six continents. C. auris consists of four discrete clades, based on where the first isolates of the clade were reported, South Asian (clade I), East Asian (clade II), African (clade III), and South American (clade IV). These clades have unique genetic and biochemical characteristics that are important to understand and inform the global response to C. auris. Clade II has been underrepresented in the literature despite being the first one discovered. In this issue of the Journal of Clinical Microbiology, Y. J. Kwon et al. (J Clin Microbiol 57:e01624-18, 2019, https://doi.org/10.1128/JCM.01624-18) describe the largest collection of clinical isolates from Clade II, which is also the longest-running span of clinical cases, 20 years, from any single region to date. Clade II appears to have a propensity for the ear that is uncharacteristic of the other clades, which typically cause invasive infections and large-scale outbreaks. This study provides new information on an understudied lineage of C. auris and has important implications for future surveillance.


2019 ◽  
Vol 20 (16) ◽  
pp. 2041-2052 ◽  
Author(s):  
Takahiro Ushida ◽  
Daiju Matsui ◽  
Teruyoshi Inoue ◽  
Mizuka Yokoyama ◽  
Hiroshi Takatsuna ◽  
...  

2019 ◽  
Vol 71 (5) ◽  
pp. 1204-1211 ◽  
Author(s):  
Nassim Kamar ◽  
Florence Abravanel ◽  
Patrick Behrendt ◽  
Jörg Hofmann ◽  
Georges Phillippe Pageaux ◽  
...  

Abstract Background Ribavirin is currently recommended for treating chronic hepatitis E virus (HEV) infection. This retrospective European multicenter study aimed to assess the sustained virological response (SVR) in a large cohort of solid organ transplant (SOT) recipients with chronic HEV infection treated with ribavirin monotherapy (N = 255), to identify the predictive factors for SVR, and to evaluate the impact of HEV RNA mutations on virological response. Methods Data from 255 SOT recipients with chronic HEV infection from 30 European centers were analyzed. Ribavirin was given at the median dose of 600 (range, 29–1200) mg/day (mean, 8.6 ± 3.6 mg/kg/day) for a median duration of 3 (range, 0.25–18) months. Results After a first course of ribavirin, the SVR rate was 81.2%. It increased to 89.8% when some patients were offered a second course of ribavirin. An increased lymphocyte count at the initiation of therapy was a predictive factor for SVR, while poor hematological tolerance of ribavirin requiring its dose reduction (28%) and blood transfusion (15.7%) were associated with more relapse after ribavirin cessation. Pretreatment HEV polymerase mutations and de novo mutations under ribavirin did not have a negative impact on HEV clearance. Anemia was the main adverse event. Conclusions This large-scale retrospective study confirms that ribavirin is highly efficient for treating chronic HEV infection in SOT recipients and shows that the predominant HEV RNA polymerase mutations found in this study do not affect the rate of HEV clearance. This large-scale retrospective study that included 255 solid organ transplant recipients confirms that ribavirin is highly efficient for treating chronic hepatitis E virus (HEV) infection and shows that HEV RNA polymerase mutations do not play a role in HEV clearance.


Sign in / Sign up

Export Citation Format

Share Document